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A Novel Isoallergen Dau c 1.0401 in Carrot: Stability,
Allergenicity, and Comparison with Other Isoallergens
Thessa Jacob, Andrea Wangorsch, Lothar Vogel, Andreas Reuter, Vera Mahler,
and Birgitta M. Wöhrl*
Scope: Around 25% of food allergic persons in Central Europe suffer from
carrot allergy caused by the major carrot allergen Dau c 1. Three different
isoallergens, Dau c 1.01, Dau c 1.02 and Dau c 1.03 are identified. However,
information about the qualitative and quantitative composition of natural
(n)Dau c 1 is scarce.
Methods and Results: The new carrot allergen Dau c 1.0401 is identified on
the mRNA and protein level by RT-PCR and mass spectrometry. It displays
only around 60% sequence identity to the other known Dau c 1 isoallergens.
NMR and CD-spectra are typical for a well-folded protein containing both
𝜶-helices and 𝜷-strands. It showed a poor refolding capacity after incubation
at 95 °C. IgE-binding is impaired in immunoblots, whereas in inhibition
assays IgE binding to soluble Dau c 1.0401 is detected and it clearly provoked
a response in mediator release assays.
Conclusion: Dau c 1.0401 is a new isoallergen which contributes to the
allergenicity of carrots. The absence of immunoreactivity in immobilized
assays indicates that IgE binding is impaired when the protein is blotted on a
solid phase. Altogether, the results point out that its allergenicity can be
reduced upon carrot processing.
1. Introduction
The prevalence of sensitization to carrot was identified to
be at 3.6% in the European Community Respiratory Health
T. Jacob, Prof. B. M. Wöhrl
Biochemie IV - Biopolymere
Universität Bayreuth










The ORCID identification number(s) for the author(s) of this article
can be found under https://doi.org/10.1002/mnfr.202001110
© 2021 The Authors. Molecular Nutrition & Food Research published by
Wiley-VCH GmbH. This is an open access article under the terms of the
Creative Commons Attribution License, which permits use, distribution
and reproduction in any medium, provided the original work is properly
cited.
DOI: 10.1002/mnfr.202001110
Survey[1] and around 24% of food-allergic
persons in Central Europe suffer from al-
lergy to carrot,[2,3] which is one important
type of pollen-related food allergies.[4–6]
The major carrot allergen in Central Eu-
rope is Dau c 1, a Bet v 1-homologous
allergen.[7] Both allergens belong to the
family of pathogenesis related proteins
10 (PR-10).[8] Usually, patients allergic to
Bet v 1-homologous allergens are sensi-
tized to the major birch pollen allergen
Bet v 1, but show allergic cross-reactions
after the consumption of other fruits,
nuts or vegetables, e.g. celery, apple or
hazelnut.[2,4,5,9,10] Bet v 1-homologous al-
lergens share a high structure and se-
quence similarity.[11] Certain IgE anti-
bodies against Bet v 1 thus, recognize
homologous allergens, causing cross-
reactivity. Allergic symptoms to Dau c 1
are very often limited to the oral cavity
(oral allergy syndrome, OAS),[12] but in
many cases, systemic reactions were also
observed.[7,13] In contrast to the other Bet
v 1-homologous allergens, Dau c 1 can induce food allergy inde-
pendently from previous sensitization by Bet v 1.[14]
To date, three different Dau c 1 isoallergens (Dau c 1.01, Dau c
1.02 and Dau c 1.03) are known. Dau c 1.01 includes five variants,
Dau c 1.0101 toDau c 1.0105. Dau c 1.0104 is a highly IgE-reactive
variant and elicits allergic reactions in 98% of patients allergic
to carrots in Central Europe, whereas 65% of the study popula-
tion react to the Dau c 1.0201 isoallergen.[15] An interesting study
showed a reduced, but not completely abolished, allergenicity of
transgenic carrot plants in which the Dau c 1.01 and Dau c 1.02
genes were silenced, indicating that additional isoallergens must
be present.[16] In 2012, the identification of the novel isoallergen
Dau c 1.0301 was published.[17]
For Bet v 1, 18 different isoallergens and variants have been un-
ambiguosly identified so far[18] and recently, a quality and potency
profile of eight recombinant isoallergens which largely mimick
the total Bet v 1 specific IgE binding of birch pollen has been
established.[19] Most likely, other PR-10 allergens also consist of
many isoallergens and variants which have not been identified
yet.
So far, no studies exist on the qualitative and quantitative
composition of Dau c 1 isoallergens and variants present in
carrot. However, a detailed analysis of the allergen composition
in carrots is necessary in order to improve recombinant allergen
formulations for diagnosis and therapy.
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Figure 1. Amino acid sequence alignment of known Dau c 1 isoallergens and the Dau c 1.0401 sequence identified by LC-MSE. Differing sequence
stretches are colour-coded. Peptides which were detected by LC-MSE are underlined. The positions of the amino acids in the sequence were labeled
according to the following scheme: e.g., T6 means that the corresponding peptide is released after “T”-(Trypsin) cleavage and starts at amino acid
position 6. Gaps indicate trypsin cleavage sites. An X indicates a missing trypsin cleavage site and was used to adjust the alignment.
Peptide mass fingerprints (PMF) of purified natural (n)Dau
c 1 isolated from carrot revealed that the protein mixture con-
tains at least eight isoallergens/variants that have not been
identified previously.[20] This study describes the detection
and biochemical, biophysical and immunological characteriza-
tion of a new Dau c 1 isoallergen, designated and accepted
by the WHO/IUIS Allergen Nomeclature Sub-Committee as
Dau c 1.0401.
2. Results and Discussion
2.1. Cloning and Sequence Analysis of the New Dau c 1.0401
Isoallergen
Recently, we thoroughly investigated the stability of nDau c 1
isolated from carrot roots and of several recombinant (r)Dau c
1 isoallergens at different pH values and temperatures.[20] In
the course of this project, LC-MSE was performed to identify the
components of nDau c 1.[20] Surprisingly, the isoallergen/variant
composition of nDau c 1 was more complex than previously
thought. Nevertheless, the known isoallergens Dau c 1.0103 and
Dau c 1.0201 could be unambigously identified in the purified
nDau c 1 mixture (Figure 1). Numerous Dau c 1-like peptides
showed sequence similarity to known Dau c 1 isoallergens
but could not be assigned to any of them. However, using this
method we were able to confirm the existence of the novel Dau
c 1.0401 protein with a sequence coverage of 81% (Figure 1).[20]
The hypothetical protein was already deposited (UniProt entry
A0A161×1M2) and derived from a whole shotgun entry of carrot
(EMBL:KZM86183.1). To confirm the complete sequence, we
isolated RNA from carrot roots, and performed RT-PCR using a
polyT primer to obtain cDNA derived solely from mRNA. Using
the shotgun entry data set, 5’ and 3’ primers complementary to
the untranslated regions (UTRs) of the putative Dau c 1.0401
mRNA were designed and used for amplification (Figure S1,
Supporting Information). The resulting DNA fragment was
cloned into the pCRBlunt vector and sequenced (Figure S1,
Supporting Information). Amino acid sequence comparison
with the protein from the shotgun entry exhibited 100% se-
quence identity; thus, confirming the presence of the molecule
on the mRNA level. Dau c 1.0401 has an amino acid identity
of approximately 60% to Dau c 1.0301, Dau c 1.01 variants and
Dau c 1.0201 (Table 1). Dau c 1.0401 comprises 155 amino acids,
has a deduced molecular weight of 16,620 Da and a theoretical
pI of 4.66. Figure 1 shows the alignment of known Dau c 1
Table 1. Amino acid identity matrix of all known and listed Dau c 1 isoal-
lergens and variants and the new isoallergen Dau c 1.0401.
Dau c 1 0.0301 0.0103 0.0104 0.0105 0.0102 0.0201 0.0401
.0301 100.0 70.1 70.1 71.4 69.5 49.0 61.0
.0103 70.1 100.00 96.1 97.4 96.7 51.0 58.4
.0104 70.1 96.1 100.0 98.7 98.0 51.0 58.4
.0105 71.4 97.4 98.7 100.0 98.0 51.0 59.1
.0102 69.5 96.7 98.0 98.0 100.0 51.0 57.8
.0201 49.0 51.0 51.0 51.0 51.0 100.0 59.7
.0401 61.0 58.4 58.4 59.1 57.8 59.7 100.0
Sequences with less than 67% identity are highlighted in dark blue, between 67 and
90% in light blue and above 90% in cyan. Data are based on the LC-MSE data from.[20]
isoallergens and the Dau c 1.0401 sequence identified previously
by LC-MSE.[20]
2.2. Physicochemical Characterization of rDau c 1.0401
We have previously shown by analysing recombinant proteins
that the protein stability of different Dau c 1 isoallergens/variants
varies significantly. Some of them, i.e., rDau c 1.0104 or rDau c
1.0105, regain their three-dimensional structure after heating at
pH 7, whereas rDau c 1.0201 does not.[20] To analyze the ther-
mostability of rDau c 1.0401, we expressed the tagless, recombi-
nant (r) protein in E. coli and purified it to homogeneity (Figure
S2, Supporting Information). Its identity was confirmed by LC-
MSE (Table S1).
Proper 3D-folding of rDau c 1.0401 was demonstrated by a
1D-NMR spectrum, which reveals the signal dispersion typical
for a well-folded protein (Figure 2A). Analytical size exclusion
chromatography (SEC) showed one single peak indicating homo-
geneity of the purified protein. The determinedmolecular weight
of approx. 24 kDa (Figure 2B) implies that rDau c 1.0401 is a
monomer and does not form oligomers under the experimental
conditions. The higher molecular weight compared to the theo-
retical (16.6 kDa) and the molecular weight determined by SDS-
PAGE (16 kDa, Figure S2) is a consequence of the shape of the
protein and/or hydration by solvent molecules.
To investigate the refolding capacity of the protein upon heat-
ing we recorded CD-spectra of rDau c 1.0401. The spectrum at
25 °C (Figure 2C, black curve) is typical for a protein with 𝛼-
helices and 𝛽-strands and closely resembles the spectra of the
other known Dau c 1 isoallergens.[20] At 95 °C, the protein was
unfolded (Figure 2C, blue curve) and after recooling to 25 °C, it
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Figure 2. Physicochemical characterization of rDau c 1.0401. A) 1D NMR spectrum B) Analytical SEC using a Superdex 75 GL10/300 column C) CD
spectra at 25 °C (black curve), 95 °C (blue curve) and after recooling to 25 °C (red curve), D) denaturation (black) and renaturation (red) curve of Dau c
1.0401.
only partially regained secondary structure elements (red curve).
The denaturation and renaturation curves confirmed the partial
refolding. A melting temperature of 65.3 °C could be determined
(Figure 2D) which was verified by nanoDSF (Supplementary Fig-
ure S3). The Tm is 5–10 °C higher than the Tm values obtained
previously for other known Dau c 1 isoallergens.[20] For Bet v
1.0101, it could be demonstrated that increased fold stability of
the allergen increases its allergenicity.[21]
2.3. IgE Binding to rDau c 1.0401
To investigate binding of IgE antibodies to rDau c 1.0401 we car-
ried out several experiments with 19 sera of carrot-allergic pa-
tients that exhibited mild to severe clinical symptoms. Sensitiza-
tion to carrot was either tested by open food challenge, skin prick
testing or prick-to-prick testing (carrot cv Rodelika) (Table 2). IgE
immunoblots using non-reducing and reducing (30 mM DTT)
conditions for the SDS-PAGE were performed. Interestingly, us-
ing the sera listed in Table 2, no bands or only very weak bands
(#29, reducing conditions; #14 both conditions) could be detected
in the immunoblot (Figure S4). Similar results were obtained
when we carried out dot blots with purified rDau c 1.0401 (Sup-
plementary Figure S5). Here the protein is directly applied to the
nitrocellulose membrane without prior denaturing.
Additionally, we performed enzyme-linked immunosorbent
assays (ELISAs) with rDau c 1.0401 (Supplementary Figure S6,
A and B, respectively). The isoallergen rDau c 1.0104 was used
as a positive control since this isoallergen was shown to possess
the strongest IgE-binding capacity.[15] Weak IgE-binding to Dau
c 1.0401 could be observed, whereas IgE-binding to the rDau c
1.0104 contol, was at least 10-fold higher. Thus, we postulated
that the protein either does not effectively bind IgE at all or irre-
versibly changes its structure when applied to solid phases, which
in turn impairs IgE-binding or renders epitopes inaccessible to
IgE antibodies. This corresponds to the results from CD spectra
(Figure 2C) which showed incomplete refolding of the denatured
protein after heating and cooling.
2.4. rDau c 1.0401 Triggers Mediator Release
To investigate whether rDau c 1.0401 is yet a functional allergen,
we performed mediator release assays (MRAs) with 19 sera of
carrot-allergic patients (Table 2). In contrast to the experiments
described above, here, rDau c 1.0401 is kept in solution. Six of the
sera tested (#5, #14, #15, #25, #29, #44) inducedmediator release
upon rDau c 1.0401 addition (Figure 3). Four of them exhibited a
strong reaction, proving the allergenicity of rDau c 1.0401.
2.5. rDau c 1.0401 Inhibits IgE-Binding of rDau c 1.0104
To confirm the results obtained with the MRAs (Figure 3) and
to unambiguously verify the IgE-binding properties of rDau c
1.0401, we resorted to inhibition assays, which show whether
soluble rDau c 1.0401 preincubated with serum can thereby
inhibit IgE-binding of immobilized rDau c 1.0104. Of course,
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Provocation Skin test CAP [kUA L
-1] (CAP class)
Patient symptoms OFC Carrot Carrot (F31) r Bet v 1.0101 r Dau c 1.0104 r Dau c 1.0201 rDau c 1.0301 rDau c 4
4 OAS, CU Pos Pos 0.10 (0) 6.62 (3) 0.00 (0) 2.04 (2) 0.04 (0) 0.01 (0)
5 OAS Nd Pos 2.76 (2) >100 (6) 5.82 (3) 17.00 (3) 6.13 (3) 0.05 (0)
14 OAS (mild) Pos Pos 0.07 (0) 43.10 (4) 5.25 (3) 4.32 (3) 9.75(3) 2.11 (2)
15 OAS Pos Pos 2.82 (2) 35.90 (4) 3.70 (3) 4.32(3) 3.57 (3) 0.09 (0)
21 OAS Nd Pos 0.79 (2) 7.56 (3) 1.17 (2) 1.43 (2) 1.38 (2) 0.02 (0)
22 U, D Pos Pos 0.71 (2) 2.58 (2) 0.02 (0) 0.17 (0) 0.09 (0) 0.05 (0)
25 OAS Pos Pos 5.20 (3) 55.80 (5) 10.50 (3) 4.90 (3) 7.93 (3) 1.48 (2)
26 Q, D, U Nd Nd 0.05 (0) 7.14 (3) 0.85 (2) 0.20 (0) 0.67 (1) 0.03 (0)
27 GI, Q Nd Neg 0.25 (0) 16.60 (3) 0.82 (2) 0.40 (1) 3.12 (2) 0.05 (0)
28 OAS Pos Pos 2.20 (2) 9.28 (3) 2.53 (2) 1.55 (2) 2.61 (2) 0.88 (2)
29 OAS Pos Pos 2.51 (2) 11.90 (3) 1.95 (2) 0.77 (2) 0.92 (2) 5.31 (3)
30 OAS Pos Pos 0.62 (1) 5.35 (3) 0.643 (1) 0.91 (2) 0.73 (2) 0.05 (0)
31 OAS, D Pos Pos 0.44 (1) 3.16 (2) 0.59 (1) 0.45 (1) 0.48 (1) 0.22 (0)
38 OAS Pos Pos 1.05 (2) 10.50 (3) 0.69 (1) 1.06 (2) 1.06 (2) 0.04 (0)
39 OAS Nd Nd 0.13 (0) 0.00 (0) 0.00 (0) 0.01 (0) 0.03 (0) 0.00 (0)
40 OAS, GI Pos Neg 0.42 (1) 29.40 (4) 1.29 (2) 2.28 (2) 1.28 (2) 0.03 (0)
44 OAS Pos Pos 24.00 (4) >100 (6) 28.40 (4) 16.60 (3) 28.40 (4) 0.54 (1)
46 OAS Pos Pos 8.16 (3) 0.06 (0) 4.86 (3) 14.40 (3) 6.92 (3) 0.18 (0)
47 OAS n.d. Neg 0.02 (0) 0.05 (0) 0.02 (0) 0.03 (0) 0.01 (0) 0.06 (0)
CU, contact urticaria; D, dyspnea; GI, gastrointestinal symptoms; nd, not determined; OAS, oral allergy syndrome; Q, Quincke’s edema; U, urticaria. Nineteen carrot-allergic
patients, selected by positive case history (OAS or systemic reactions) of carrot allergy were included in the study. Sensitization to carrot was tested by prick-to-prick testing
(carrot cv Rodelika), and open food challenge (OFC). Specific IgE against carrot extract, the PR-10 allergens rBet v 1.0101, rDau c 1.0104, rDau c 1.0201, rDau c 1.0301 and
the profilin rDau c 4 were determined in experimental ImmunoCAP measurements and assigned to the respective CAP class.
Figure 3. MRAs of rDau c 1.0401 with sera of six carrot-allergic patients.
Patient sera (serum #5, blue lines; #14, black lines;#15, grey lines; #25,
red lines; #29, green lines; #44, brown lines) were incubated with increas-
ing amounts of rDau c 1.0401.
a prerequisite for a positive result is the presence of common
epitopes between the two tested isoallergens.
We tested sera from four carrot allergic patients (sera #14,
#15, #25, #44) that induced mediator release upon rDau c 1.0401
addition (Figure 3). They were preincubated either with rDau
c 1.0104 (self inhibition) or rDau c 1.0401 to perform dose-
dependent IgE competition assays (Figure 4) in which rDau c
1.0104 was used on the solid phase. Pre-incubation with each
of the two isoallergens resulted in IgE inhibition. After self
inhibition 100% inhibition of IgE-binding was achieved at 10 𝜇g
of rDau c 1.0104 in the solution. For rDau c 1.0401 a similar
inhibitory effect occurs only with serum #25, whereas the other
three sera show less inhibition. Our data indicates that IgEs of
serum #25 recognize the same or similar epitopes of rDau c
1.0104 and rDau c 1.0401, whereas in sera #14, #15, and #44
additional types of IgE antibodies are present that recognize
solely epitopes on rDau c 1.0104 but not on rDau c 1.0401. As
IgE-binding of rDau c 1.0401 is impaired when blotted on a
membrane (Supplementary Figure S4-S6), it was not possible
to perform inhibition assays in the other direction, i.e., using
immobilized rDau c 1.0401.
In summary, these results suggest that rDau c 1.0401 harbors
epitopes that are modified, denatured or not accessible when the
allergen is bound to solid membranes, but can be recognized by
IgEs if the native allergen is used in inhibition assays or MRAs.
We assume that this behavior can occur also with other PR-10
allergens and this needs to be considered if the allergenicity of
new isoallergens is determined.
2.6. Comparison of Dau c 1 Isoallergens
To compare the allergenicity of the new allergen rDau c 1.0401
with other known Dau c 1 isoallergens, we performed MRAs
with purified different recombinant Dau c 1 isoallergens using
five different sera (Figure 5). Intriguingly, serum #14 (black),
#44 (brown), #5 (blue) and #25 (red) reacted with rDau c 1.0104,
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Figure 4. Inhibition of IgE-binding to rDau c 1.0104. Sera from carrot allergic patients (as indicated) were incubated with increasing amounts of either
rDau c 1.0104 (black curves, self inhibition) or rDau c 1.0401(red curves). The ELISAs were performed with rDau c 1.0104 on the solid phase. IgE binding
of rDau c 1.0104 after pre-incubation with 25 𝜇g mL-1 BSA as a negative control is shown as a grey data point.
rDau c 1.0301, rDau c 1.0401 and nDau c 1, suggesting that those
isoallergens possess common epitopes. Remarkably, serum #44
(brown lines) was the only one that reacted with rDau c 1.0105,
although this variant only differs in two amino acids from Dau c
1.0104 (D43E and E139A, depicted in red in Figure 6A,C), imply-
ing that those amino acids might be crucial for epitope recogni-
tion.
Serum #46 (Figure 5 grey lines) reacted exclusively with rDau c
1.0201, indicating that this isoallergen contains unique epitopes.
Since serum #46 (grey lines) exhibited no reaction with nDau c
1, we assume that the concentration of Dau c 1.0201 in purified
nDau c 1 is too low to induce a reaction. Apart from serum #5
(blue lines), which shows weak reactivity, none of the other sera
tested reacted with rDau c 1.0201.
We suggest that epitopes may be present which are conserved
between rDau c 1.0104, rDau c 1.0201 and rDau c 1.0301, but not
rDau c 1.0201. Figure 6 shows an amino acid sequence compar-
ison of all tested Dau c 1 isoallergens. Homologous amino acid
stretches exist that are present in all rDau c 1 isoallergens except
rDau c 1.0201 (cyan) and thusmight form epitopes which are not
present in rDau c 1.0201.
3. Concluding Remarks
Dau c 1.0401 was accepted by the WHO/IUIS Allergen Nomen-
clature Sub-Committee as a new Dau c 1 isoallergen. Our results
prove that Dau c 1.0401 functions as an allergen as shown
by MRAs and inhibition assays. The fact that IgE-binding is
inhibited when rDau c 1.0401 is applied to a solid phase is
rather unusual and implies that false negative results have to be
considered if IgE-binding of novel potential allergens is solely
analyzed with methods that require the protein to be fixed onto a
solid phase. Our data imply that after membrane binding of Dau
c 1.0401 most epitopes are no longer accessible or are denatured.
As CD spectra demonstrate that the 3-D structure of rDau c
1.0401 is lost when heated and is not completely recovered when
cooled down to room temperature, Dau c 1.0401 concomitantly
will lose its allergenic potential upon heating, However, other
thermostable isoallergens present in nDau c 1 can still provoke
an allergic reaction. The knowledge of new isoallergens and
their biophysical and immunological behavior is key to the
improvement of component resolved diagnosis of carrot allergy
and to the generation of potential hypoallergens for food allergy
immunotherapy.
4. Experimental Section
Identification of Dau c 1.0401 mRNA: RNA was isolated from approx.
200mg of freeze-dried, ground carrots using the RNA plant extractionmini
kit (Qiagen, Hilden, Germany). Subsequently, total cDNA was prepared
using the SuperScript IV First-Strand Synthesis System with ezDNase En-
zyme (Thermo Fisher, Schwerte, Germany).
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Figure 5. MRAs with different Dau c 1 proteins and sera of five carrot-allergic patients. Patient sera (serum #5, blue lines; #14, black lines; #25, red
lines; #44, brown lines; #46, grey lines) were incubated with increasing amounts of Dau c 1 proteins.
Primers in the 5′ UTR (5′ -CACAGCATTCCTTGATAAGCTC, forward)
and 3′ UTR (5′-CCATCCAGGTCTCACGAACA, reverse) region of the Dau c
1.0401 protein (Uniprot Accession number: A0A161×1M2) were designed
based on its hypothetical mRNA (https://www.ncbi.nlm.nih.gov/nuccore/
XM_017360362.1). Dau c 1.0401 cDNA was amplified by PCR and cloned
into the pCR-Blunt vector using the Zero Blunt PCR Cloning Kit (Thermo
Fisher). The Dau c 1.0401 sequence of isolated plasmids was confirmed
by Sanger Sequencing (Eurofins, Ebersberg, Germany).
Cloning, Expression and Purification of rDau c 1.0401: A codon-
optimized Dau c 1.0401 gene strand was purchased (Eurofins) and cloned
into the bacterial expression vector pET11a (Merck (Novagen), Darm-
stadt, Germany). Recombinant gene expression and cell lysis were per-
formed as described for Bet v 1.0101.[22] After cell lysis, (NH4)2SO4 pre-
cipitation in two steps (40% and 100% saturation) was performed at 4 °C
as described previously for nDau c 1.[20] The sample was then subjected to
hydrophobic interaction chromatography (HIC) or anion exchange chro-
matography. HIC was performed as described for Dau c 1.0301.[20] An-
ion exchange chromatography was performed using a HiTrap QXL column
(GEHealthcare) by stepwise increasing the concentration of elution buffer
(20 mM Tris/HCl, pH 8.0, 1 M NaCl). Dau c 1-containing elution fractions
were pooled and size exclusion chromatography (SEC) was performed.[20]
After SEC, Dau c 1.0401 was dialyzed against 10 mM Na-phosphate,
pH 7.0 overnight at 4 °C, shock-frozen in liquid nitrogen and stored at
–80 °C.
Patients’ Sera: Sera from carrot allergic patients were obtained af-
ter patient written consent and approval of ethics committee (Faculty of
Medicine, University of Erlangen-Nuremberg, No. 3494).
CD Spectroscopy, nanoDSF, MRAs, IgE Immunoblots and IgE Inhibition
by ELISA: Circular dichroism (CD) spectroscopy, nano differential scan-
ning fluorimetry (nanoDSF), MRAs and IgE immunoblots were performed
as described previously.[17,20,23] For the ELISAs rDau c 1.0104 was coated
overnight to Maxisorp plates as described.[17]
Dot Blots: Two or 4 𝜇g protein was dotted to 0.45 𝜇m nitrocellulose
membranes, dried for 30 min and blocked using TBS + 0.3% Tween, 2
× 30 min, followed by incubation with 500 𝜇L/strip patient’s serum 1:10
in TBS + 0.05% Tween (TBST 0.05%) + 0.1% BSA overnight at RT on a
shaker. IgE detection was performed after 4x washing with TBST 0.05%,
incubation with anti human IgE-AKP (mouse mAB, Pharmingen 555859)
1:750 in TBST 0.05%, 1 mL/strip, 4 h at RT on a shaker, 5x washing (as
above), NBT/BCIP staining.
Mass Spectrometry of rDau c 1.0401: Mass spectrometry was per-
formed in commercial service (Department of Biochemistry, University
of Bayreuth). The method is therefore only described in so far as it
serves the understanding. The band of the putative Dau c 1.0401 was
cut from a 19% SDS-gel (Figure S2) and trypsinized.[24] LC-ESI-MS/MS
of 5 𝜇L of the sample was performed on an LTQ-XL mass spectrometer
(Thermo Scientific) coupled with an EASY-nLC II chromatographic system
(Thermo Scientific) using an in-house packed column with ReproSil-Pur
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Figure 6. Sequence comparison of the tested Dau c 1 isoallergens. A) Cartoon representation of the Dau c 1.0105 model (Phyre 2). The two amino acid
exchanges between Dau c 1.0104 and Dau c 1.0105 (D43E and E139A) are highlighted in red. B) Cartoon representation of the Dau c 1.0401 model
(Phyre 2). Conserved surface patches of all tested isoallergens are highlighted in dark blue, and conserved surface patches of all isoallergens except Dau
c 1.0201 in cyan. C) Amino acid sequence alignment of all tested isoallergens. Colours are used as in A) and B). Secondary structure elements (yellow:
𝛽-strands, orange: 𝛼-helices) are depicted above the sequence as determined for Dau c 1.0401.
C18-AQ 3 𝜇m beads (Dr. Maisch GmbH, Ammerbuch, Germany). Pro-
tein identification was performed using the Byonic software (Protein
Metrics).
Modelling of Dau c 1 Isoallergens: Dau c 1.0105 and Dau c 1.0401 were
modelled using the Phyre 2 server V 2.0.[25]
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